SAT-313 Synaptojanin 2 Binding Protein Is Required for Efficient Somatostatin Receptor 2A Phosphorylation by G Protein Coupled Receptor Kinases and Signaling to the ERK/MAPK Pathway

Somatostatin receptor 2A (Sst2A) agonists are the primary pharmacological treatment for growth hormone (GH) secreting pituitary tumors to inhibit GH secretion and limit the destructive effects of these tumors. Sst2A agonists are also widely used as imaging agents for neuroendocrine tumors, and are u...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Heather S, Frost, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207474/
http://dx.doi.org/10.1210/jendso/bvaa046.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207474/
http://dx.doi.org/10.1210/jendso/bvaa046.085

Ejemplares similares